PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMOURS THAT EXPRESS EGFR AND GANGLIOSIDE N-GLYCOLYL GM3 (NEUGCGM3)

The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N- glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical composit...

Full description

Saved in:
Bibliographic Details
Main Authors BARROSO ALVAREZ, MARÍA DEL CARMEN, BLANCO SANTANA, RANCÉS, MONTERO CASIMIRO, JOSÉ ENRIQUE, MACÍAS ABRAHAM, AMPARO, EMILIA, CARR PEREZ, ADRIANA, GONZÁLEZ PALOMO, ADYS, LEÓN MONZÓN, KALET
Format Patent
LanguageEnglish
Published 26.09.2014
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N- glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.
Bibliography:Application Number: SG20141103014X